Serina Therapeutics Cash Flow Statement (2018-2025) | SER

Cash Flow Statement Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -0.32M-1.95M-2.19M-3.27M-3.21M-3.15M-3.28M-2.74M-0.19M-0.30M-0.04M-0.20M-0.10M-2.71M-2.62M-2.44M-2.76M-1.05M-1.05M-1.56M0.07M-2.51M-4.17M-5.33M-5.57M-5.86M-5.57M-6.40M
Depreciation and Depletion 0.01M0.01M0.02M0.01M0.01M0.01M0.12M0.05M0.12M0.12M0.12M0.33M0.01M0.02M0.03M0.22M0.02M
Share-based Compensation 0.14M0.23M0.21M0.80M0.48M0.52M0.49M0.42M0.25M0.25M0.23M0.18M0.18M0.29M0.27M0.26M0.24M0.20M0.21M0.11M0.00M0.02M0.04M0.05M0.46M1.10M0.99M0.96M0.89M1.00M
Cash from Discontinued Operations 0.18M-0.09M-0.09M
Gains from Sales and Divestitures 0.00M0.02M0.02M0.01M0.01M0.01M0.01M0.01M0.00M0.00M0.00M
Gains from Investment Securities 3.21M4.00M4.00M0.08M2.84M2.96M2.85M2.85M3.38M3.37M0.09M0.17M-0.04M0.01M-0.17M-0.29M-0.60M-0.02M-9.30M-6.70M-2.76M-0.99M1.00M-1.04M
Non-cash Items 1.30M0.95M0.95M1.28M0.01M2.04M1.86M1.86M0.24M2.25M0.11M2.71M2.83M0.00M2.97M3.02M3.07M0.08M
Cash from Operations -2.00M-2.16M-1.78M-2.05M-2.62M-2.76M-2.37M-2.41M-2.24M-2.15M-1.80M-1.81M-2.63M-1.69M-1.88M-1.65M-1.64M-1.75M-1.24M-1.32M-0.71M-0.86M-1.02M0.12M-1.58M-8.01M-2.96M-4.59M-4.32M-3.78M-3.82M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.11M0.11M0.12M0.14M0.14M0.14M0.14M0.14M0.10M0.03M0.14M0.01M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M
Amortization of Deferred Charges 0.04M0.05M0.08M0.15M0.21M0.27M0.27M0.28M0.29M0.54M0.81M0.87M0.92M1.06M0.92M-1.59M0.18M0.16M0.17M0.01M0.01M
Depreciation & Amortization (CF) 0.01M0.01M0.02M0.01M0.01M0.11M0.12M0.15M0.23M0.23M0.23M0.01M0.23M0.01M0.02M0.05M0.01M0.03M0.06M0.06M0.06M0.02M0.02M0.02M
Change in Working Capital
Change in Receivables -0.05M0.07M0.07M-0.06M0.07M0.00M0.03M0.13M-0.01M-0.07M-0.01M0.12M-0.10M-0.04M0.01M0.00M-0.03M0.01M-0.01M0.00M-0.09M-0.20M0.66M0.17M-0.16M
Change in Account Payables -0.15M-0.01M0.04M-0.02M0.01M-0.46M-0.15M0.00M-0.31M-0.16M-0.24M-0.30M-0.31M-0.31M-0.33M-0.33M-0.33M-0.35M-0.36M1.23M-0.13M0.24M-1.45M0.49M-0.95M0.44M0.52M1.04M
Change in Accured Expenses 0.28M-0.13M0.09M0.41M-0.05M0.17M0.20M-0.15M0.34M-0.63M0.52M-0.81M-0.35M0.10M-0.38M-0.15M0.21M-0.41M0.11M0.24M0.23M-0.05M-0.25M-0.08M0.40M-0.60M0.33M0.27M-0.39M0.76M-0.67M
Investing Activities
Capital Expenditures 0.00M0.01M0.01M0.00M0.11M0.24M0.29M0.00M0.00M0.01M0.12M0.07M0.01M0.00M0.01M0.05M0.01M
Divestments 3.21M0.08M0.47M
Cash from Investing Activities 2.41M-0.01M-1.08M0.00M-0.00M0.09M-0.16M-0.29M-0.00M-0.00M-0.01M0.47M0.25M-10.00M9.69M-0.12M-0.07M-0.01M-0.00M-0.01M-0.05M-0.01M
Financing Activities
Other financing activities -0.25M
Debt Issuance and Repayment
Long-Term Debt Issuances 10.10M
Long-Term Debt Repayments 0.25M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.00M
Short-Term Debt issuances 2.00M1.50M1.50M2.00M1.00M1.50M11.50M2.00M-13.50M2.40M0.53M0.01M0.11M
Change in Capital Stock
Shares Issued 0.74M4.50M0.06M0.04M0.50M0.01M0.00M4.98M4.92M-4.91M0.01M
Misc.
Cash from Financing Activities 0.74M5.00M0.26M4.50M-0.01M0.49M1.29M0.18M2.81M1.98M0.99M2.75M1.25M2.00M1.50M1.50M2.00M1.00M1.50M10.09M-0.01M0.00M-0.01M2.73M5.37M0.09M5.03M4.92M5.57M6.44M
Exchange Rate Effect -0.00M0.01M-0.00M-0.00M0.00M-0.00M0.01M-0.00M-0.00M
Change in Cash 1.15M2.83M-2.60M-2.05M1.88M-2.67M-2.04M-1.42M-1.88M0.56M0.07M-0.63M0.28M-0.19M0.12M-0.15M-0.14M0.25M-0.24M0.18M9.38M-1.19M-1.14M0.04M1.14M-2.64M-2.88M0.44M0.59M1.77M2.58M
Free Cash Flow -2.01M-2.17M-1.79M-2.05M-2.62M-2.87M-2.61M-2.71M-2.24M-2.16M-1.82M-1.81M-2.63M-1.69M-1.88M-1.65M-1.64M-1.75M-1.24M-1.32M-0.71M-0.86M-1.14M0.05M-1.59M-8.01M-2.96M-4.59M-4.32M-3.82M-3.83M
Net Cash Flow 1.15M2.83M-2.60M-2.04M1.88M-2.67M-2.04M-1.42M-2.06M0.65M0.16M-0.82M0.58M-0.19M0.12M-0.15M-0.14M0.25M-0.24M0.18M-0.62M8.81M-1.14M0.04M1.14M-2.64M-2.88M0.44M0.59M1.75M2.61M